+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation



Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation



Journal of Cardiovascular Pharmacology 54(4): 335-340



This study was conducted to evaluate the acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes (AHFS), under noninvasive hemodynamic assessment with transthoracic Doppler echocardiography. After baseline hemodynamic measurements, initial bolus and 48-hour continuous intravenous nicorandil infusion were begun in 14 hospitalized patients with AHFS. After 2-hour infusion, estimated pulmonary capillary wedge pressure was reduced from 21.4 +/- 6.4 to 17.5 +/- 5.2 mm Hg (P < 0.05) and was sustained for 48 hours to 16.2 +/- 5.5 mm Hg (P < 0.05). A significant increase in estimated cardiac output was observed at 2 hours, from 4.0 +/- 1.0 to 4.8 +/- 1.3 L/min (P < 0.05). This increase was sustained for 48 hours to 5.8 +/- 1.8 L/min (P < 0.05). The high blood pressure (BP) group (baseline systolic BP > or = 140 mm Hg, n = 7) exhibited significant decrease in systolic BP (from 156.7 +/- 14.2 to 135.4 +/- 13.3 mm Hg, P < 0.05). In contrast, there was no change in systolic BP in the low BP group (baseline systolic BP < 140 mm Hg, n = 7) over 48 hours (from 107.6 +/- 20.4 to 107.7 +/- 17.4 mm Hg, P = not significant). The results of this study demonstrate the acute hemodynamic efficacy and safety of intravenous administration of nicorandil and also suggest the usefulness of noninvasive echocardiographic hemodynamic evaluation in the urgent phase of AHFS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051355968

Download citation: RISBibTeXText

PMID: 19687747

DOI: 10.1097/FJC.0b013e3181b76730


Related references

Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes. Heart and Vessels 28(3): 345-351, 2013

Efficacy and safety of nicorandil therapy in patients with acute heart failure. Journal of Cardiology 56(3): 339-347, 2011

Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. American Heart Journal 157(6): 1035-1041, 2009

Efficacy and Safety of Early Administration of Intravenous Enalaprilat in Congestive Heart Failure Patients with Acute Pulmonary Edema. Journal of the American College of Cardiology 0(SPEC ISSUE): 338A, 1995

Prognostic Value of Myocardial Perfusion SPECT After Intravenous Bolus Administration of Nicorandil in Patients with Acute Ischemic Heart Failure. Journal of Nuclear Medicine 57(3): 385-391, 2016

Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure. Journal of Cardiology 56(3): 291-299, 2011

Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial. European Heart Journal. Acute Cardiovascular Care 6(4): 329-338, 2016

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia. Journal of Clinical Medicine Research 9(5): 426-432, 2017

Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure. Angiology 40(4 Pt 2): 396-404, 1989

Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Cardiac Care 13(2): 76-80, 2011

Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome. Circulation Journal 76(5): 1169-1176, 2012

Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. Yonsei Medical Journal 58(1): 105-113, 2016

Acute hemodynamic effects of intravenous administration of pimobendan in congestive heart failure. Japanese Circulation Journal 55(SUPPL A): 270, 1991

Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 34(1): 23-27, 2006

Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance. PharmacoTherapy 36(8): 852-860, 2017